Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2
Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2 have?
Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2 has 14 citations in the OpenAlex counts ScholarIQ stores.
When was Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2 published?
Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2 has 2022 year in the ScholarIQ index.
What is the open-access status of Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2?
Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2 has diamond oa status in the ScholarIQ index.
What is the DOI of Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2?
The DOI for Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2 is on the source record.
What is the PMID of Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2?
The PMID for Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2 is on the source record.
What is the OpenAlex record for Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2?
The OpenAlex for Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2 is on the source record.